Armodafinil is discontinued (DEA controlled substance). Armodafinil, formerly known as CEP-10953, is the R-enantiomer of the racemic synthetic agent Modafinil with central nervous system (CNS) stimulant and wakefulness-promoting activities. Armodafinil appears to inhibit the reuptake of dopamine by binding to the dopamine-reuptake pump, which leads to an increase in extracellular dopamine levels in some brain regions. This agent does not bind to or inhibit several receptors and enzymes that may be involved in sleep/wake regulation and is not a direct- or indirect-acting dopamine receptor agonist. References: Kim D. Practical use and risk of modafinil, a novel waking drug. Environ Health Toxicol. 2012;27:e2012007. Epub 2012 Feb 22. PubMed PMID: 22375280; PubMed Central PMCID: PMC3286657.

纯度：≥98%

CAS：112111-43-0